Euronext door opener

The first European biotech IPO of 2012 looks to be French polymer play Adocia S.A.S., which announced details of its deal on Euronext Paris and a private placement outside the U.S.

The company said it plans to sell a total of 1.4 million shares at €13-€15.88 in the offerings. A €14.44 price would raise €20 million ($25.9 million) and value Adocia at €84.4 million ($109.1 million) based on 4.5 million shares outstanding...